by EIRadmin202001 | Jan 14, 2021 | Press Releases
Sortina Pharma AB today announces a financing led by the venture capital fund Eir Ventures and with GU Ventures, to unlock the potential of proprietary anti- sortilin cancer therapy to cure aggressive cancer. The founders of Sortina Pharma, Professor Göran Landberg...
by EIRadmin202001 | Jan 13, 2021 | Press Releases
IO Biotech develops new cancer treatments, that have proven to give outstanding responses in combination with current standard of care in melanoma (skin cancer) and Non-small cell lung cancer. Eir Ventures is delighted to announce our participation in the over...
by EIRadmin202001 | Sep 29, 2020 | Press Releases
Synklino is a Danish biotech company with technology from the University of Copenhagen and the Technical university of Denmark, focusing on developing groundbreaking therapies against devastating virus infections. Eir Ventures is happy to announce that we have lead...
by EIRadmin202001 | Sep 25, 2020 | Press Releases
Eir Ventures co-leads high profile syndicate in €55 million investment in Galecto Biotech. The company is based on science and technology stemming from Swedish academia and developed in Denmark. The technology addresses fibrotic diseases with limited or no care...
by EIRadmin202001 | Jul 10, 2020 | Press Releases
Life sciences focused fund also announces first close of EUR76 million July 10, 2020, Stockholm & Copenhagen: Eir Ventures, a Nordic Life Science Venture Fund, today announced a first close of its new fund of EUR76 million. With a strong base in the Nordic region...
Recent Comments